In line with previous literature showing that MUT p53 accelerates cancer cell motility, invasion, and metastasis [32, 43], our examination of the TCGA Pan-Cancer cohort observes a greater fraction of cancer patients developing metastases to lymph nodes or distant organs in the MUT TP53 group relative to the WT TP53 group. Here, TP53 is linked to polyarteritis nodosa.